Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent

Drug repositioning is a revolution breakthrough of drug discovery that presents outstanding privilege with already safer agents by scanning the existing candidates as therapeutic switching or repurposing for marketed drugs. Sitagliptin, vildagliptin, saxagliptin & linagliptin showed antioxidant...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayoub, Bassam M., Mowaka, Shereen, Safar, Marwa M., Ashoush, Nermeen, Arafa, Mona G., Michel, Haidy E., Tadros, Mariam M., Elmazar, Mohamed M., Mousa, Shaker A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997767/
https://www.ncbi.nlm.nih.gov/pubmed/29895906
http://dx.doi.org/10.1038/s41598-018-27395-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997767/
https://www.ncbi.nlm.nih.gov/pubmed/29895906
http://dx.doi.org/10.1038/s41598-018-27395-0

Ejemplares similares